Results 81 to 90 of about 1,449,698 (192)

Summarizing the Experiences of Individuals Who Have Obesity or Larger Bodies Seeking Fertility Care: A Scoping Review

Obesity Reviews, EarlyView.
ABSTRACT Females who have larger bodies or obesity may be at an increased risk for experiencing infertility. Problematically, both weight or body size and infertility are stigmatized, harming quality of care. We conducted a scoping review to understand the lived experiences of patients who may be subjected to intersecting stigmas of weight and ...
Brooke J. Hebert, Hanna Randhawa, Virginie Blanchette, Kristi B. Adamo, Angela Alberga, Jean‐Patrice Baillargeon, Marilou Côté, Julia Craig, Ariadne Daniel, Liz Dennett, Nicola Heslehurst, Sarah Nutter, Ian Patton, Helena Piccinini‐Vallis, Ximena Ramos Salas, Katie Wadden, Taniya S. Nagpal   +16 more
wiley   +1 more source

A cross sectional study of polycystic ovarian syndrome among pharmacy students [PDF]

, 2019
Polycystic ovarian syndrome (PCOS) is a common disorder, often complicated by chronic an ovulatory infertility and hyperandrogenism with the clinical manifestation of oligomenorrhoea, hirsutism and acne. The aim of this research is to evaluate polycystic
Dhanya Dharman, Athira J R, Radhika Nair, Reshma Rajan, Deepa Manohar, Deepthi Mariya Davis, Shaiju S Dharan   +6 more
core  

Which Is More Reliable In Polycystic Ovarian Syndrome: Body Mass Index or Waist Hip Ratio? [PDF]

, 2015
This was a prospective study, to compare between body mass index (BMI) and waist hip ratio (WHR) in polycystic ovarian syndrome (PCOS). 120 PCOS patients, infertile and anovulatory, have been chosen.
Nada, Zakaria
core   +1 more source

Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks

Experimental Physiology, EarlyView.
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan, Stephanie Cowan, Chau Thien Tay, Lisa J. Moran, Ashley H. Ng   +4 more
wiley   +1 more source

Polycystic Ovarian Syndrome (PCOS) and its Scope in Homoeopathy

PCOS was originally described in 1935 by Stein and Leventhal as a syndrome manifested by Amenorrhoea, hirsutism and obesity associated with enlarged polycystic ovaries. It’s a common endocrine disorder in a woman of reproductive age.1 Keywords- PCOD/PCOS,
Dr Poornnima G
core   +1 more source

Real‐World Metabolic Improvements in Women With and Without Polyendocrine Metabolic Syndrome via a Multidisciplinary Telehealth Care Platform

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
In this retrospective cohort of 919 women with BMI ≥ 25 (557 PCOS, 362 non‐PCOS), a multidisciplinary telehealth platform produced significant improvements across eight metabolic markers over 9.6 months. Improvements were equivalent between groups despite a more adverse baseline metabolic profile in PCOS, supporting telehealth as scalable metabolic ...
Heather G. Huddleston, Rachel Blank, Nandita Sommers, Nicole Hellman, Felice Ramallo, Tiffany Pham, Karla Lindquist   +6 more
wiley   +1 more source

Dietary Management of Polycystic Ovarian Syndrome (Pcos)

International Journal of Women’s Health Care, 2017
Polycystic Ovarian Syndrome (PCOS) is an endocrine disorder found in women, which has increasingly become common now due to the changes in lifestyle. Explanation for the increasing number of incidents can be attributed to the change in diet in most parts of the world.
openaire   +1 more source

Gene‐Guided Therapy in Type 2 Diabetes Mellitus: An Integrative Review of the Pharmacogenetics of Metformin and Sodium‐Glucose Cotransporter‐2 Inhibitors

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
Genetic variation influences the pharmacological response to metformin and SGLT2 inhibitors in patients with type 2 diabetes mellitus. Pharmacogenetic biomarkers affecting drug transport, metabolism and target activity contribute to inter‐individual differences in treatment efficacy and adverse effects, supporting the implementation of personalized ...
Imran Hossain, Mahnoor Haidar, Mahfuj Ahmed Ratul, Jannatul Ferdous Sumona, Sraboni Shabnaz, Abul Fojal Nokib, Fatema‐Tuz‐Zohora   +6 more
wiley   +1 more source

Cardiometabolic aspects of polycystic ovarian syndrome

, 2007
Li Wei Cho1, Harpal S Randeva2, Stephen L Atkin11Department of Medicine, University of Hull; 2Metabolic Unit, University Hospitals Coventry & Warwickshire NHS Trust, UKAbstract: It is estimated that 6%–7% of women of reproductive age have ...
Li Wei Cho, Harpal S Randeva, Stephen L Atkin   +2 more
core  

Application of Herbal Medicines for Obesity Treatment in the Polycystic Ovarian Syndrome Women

, 2020
Polycystic ovarian syndrome (PCOS) is a frequent disorder commonly found in reproductive-aged women. The disease PCOS in women is considered to be complex heterogeneity, which indicates the combined combination of genetics and environmental interaction
Sameera A. Alghamdi
core   +1 more source